Kicqstart primers for TBP, KEAP1, NFE2L2, SRXN1 and SQSTM1 (Sigma Aldrich, Zwijndrecht, The Netherlands) were used to detect mRNA levels using POWRUP SYBR master mix (Thermo Scientific, Leiden, The Netherlands)
Tirzepatide's dual GLP-1/GIP mechanism produces lower diarrhea rates (~23%) than retatrutide's triple agonist approach
Flushing or warmth, a brief headache, or mild nausea especially if an infusion is run too quickly (slowing the infusion usually helps)
For example, if you are living with obesity or are overweight (BMI 27), and have previously had a heart attack, a stroke or poor blood flow to the limbs, you may be eligible for treatment